HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,658,160 | +3.6% | 52,000 | -1.5% | 0.02% | +6.7% |
| Q2 2023 | $4,495,392 | +19.9% | 52,800 | +16.6% | 0.02% | +15.4% |
| Q1 2023 | $3,748,575 | +1078.8% | 45,300 | +906.7% | 0.01% | +1200.0% |
| Q3 2021 | $318,000 | -69.9% | 4,500 | -52.6% | 0.00% | -66.7% |
| Q1 2021 | $1,055,000 | -6.5% | 9,500 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $1,128,000 | +36.1% | 9,500 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $829,000 | -57.1% | 9,500 | -56.0% | 0.00% | -25.0% |
| Q2 2020 | $1,934,000 | -10.1% | 21,600 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $2,152,000 | +126.3% | 21,600 | +1.9% | 0.01% | +25.0% |
| Q3 2017 | $951,000 | +225.7% | 21,200 | +194.4% | 0.00% | +300.0% |
| Q1 2017 | $292,000 | -53.8% | 7,200 | -67.0% | 0.00% | -66.7% |
| Q2 2016 | $632,000 | – | 21,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |